Workshop: In vitro methods in practice
This day is offering a theoretical base with different lectures on research forefront and financing opportunities. The workshop originally included a practical session on site, but due to the covid-19 […]
This day is offering a theoretical base with different lectures on research forefront and financing opportunities. The workshop originally included a practical session on site, but due to the covid-19 […]
Dec. 1st at 1:10pm EDT As part of the "Sensitization: Skin & Beyond" science panel, Dr. Andy Forreryd at SenzaGen will be presenting a talk titled: "The GARD Platform for […]
In vitro, high accuracy, broad applicability Join this free webinar to learn how the GARD™ assays, based on genomics and machine learning, provide a highly accurate method for skin sensitization […]
User cases on hazard and potency assessment Join us for this free webinar to get the latest news about the in vitro GARD™ assays and how they are used across […]
Webinaire en français (in French) Participez à ce webinaire sur les nouvelles technologies in vitro utilisées pour l’évaluation des produits cosmétiques organisé par PKDerm, GenEvolutioN et SenzaGen avec la participation de CEHTRA […]
Booth #2062 Program The official meeting time zone is US Eastern Daylight Time, UTC -4. Please consult the World Time Zone Map for further guidance regarding the time conversions. March 16 […]
In case you missed our poster presentations at this year's Society of Toxicology Annual Meeting, here is a new opportunity. Register to get the latest updates on the GARD™ assays and […]
Determining if a new cosmetic product, pharmaceutical ingredient, or chemical substance is harmful to humans is a key prerequisite for product safety and consumer protection. Traditionally, skin sensitization testing relied […]
In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for qualitative and quantitative skin sensitizing potency assessment, filling in data […]
This presentation will introduce GARDskin Dose-Response assay, a novel approach for the assessment of relative skin sensitizing potency on a continuous scale. Results demonstrate that induction of toxicity pathways in […]